Orphan drug designation is granted by the FDA for therapies treating rare disease affecting fewer than 200,000 patients in the U.S., and provides development incentives including extended market ...

Precision DNA editing gene therapy achieves deep remissions in aggressive leukemia previously considered incurable.

WICHITA, Kan. (KWCH) - Kansas children battling leukemia have a new hope for survival thanks to a new treatment available in Wichita. KU School of Medicine-Wichita Doctors Nathan Hall and Brian Pate ...

CURE sat down with Dr. Tanja A. Gruber of Stanford Medicine Children’s Health to discuss clinical trials in infant leukemia. Recent advancements have brought optimism when it comes to treating infant ...

Family who lost one to leukemia while brother receives treatment gets new help in Visalia In Rodman, Hayes said she has ...

MUSC researchers at the Hollings Cancer center are making strides in new developments for leukemia treatment. Sophie Paczesny, M.D., Ph.D., the principal investigator for this new research, and the co ...

Receiving a diagnosis of Chronic Myeloid Leukemia (CML) can be frightening, but it is important to understand that the management of this disease is one of the greatest success stories in modern ...

KCCI EIGHT NEWS AT TEN. DES MOINES SECOND GRADER JUST CELEBRATED A MAJOR MILESTONE. KCCI LAURA TERRELL HAS THE STORY THAT WILL NO DOUBT BRING YOU JOY. GABE FULLER IS USED TO THIS ROUTINE. BY NOW.

SEER based nomograms predicted overall and cancer specific survival in acute erythroid leukemia, with age and chemotherapy ...

A leukemia diagnosis can feel like a sudden storm, upending lives and leaving patients and families grappling with uncertainty. This blood cancer, which affects the body’s ability to produce healthy ...

After adjustment for other factors, a CFS of 3 or higher and relapsed/refractory disease were the only independent predictors of early zanubrutinib discontinuation.